Welcome to the Codexis Investor Relations Headquarters
Codexis, Inc. at 17th Annual B. Riley Investor Conference (Live)
05/25/16 at 9:30 a.m. PT
Codexis, Inc. (Nasdaq: CDXS) is a leading protein engineering company that applies its technology to the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. Codexis' proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing.
Sign up for E-mail Alerts
You may automatically receive Codexis, Inc. information by e-mail
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.